Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report

Gynecol Oncol. 2002 Nov;87(2):231-4. doi: 10.1006/gyno.2002.6824.

Abstract

Background: Ovarian cancer arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy is rare.

Case: We herein report the case of a 67-year-old woman with a history of breast cancer, taking tamoxifen citrate 20 mg/day for 4 years, who underwent an operation for left ovarian tumor. The postoperative histological diagnosis was endometrioid adenocarcinoma in an endometriotic cyst with a gradual transition of the degree of cellular atypia noted from typical endometriotic epithelium, to atypical endometriosis, and finally to adenocarcinoma.

Conclusion: Tamoxifen may cause malignant transformation of endometriosis through atypical endometriosis even in the postmenopausal state. Atypical endometriosis may act as a precancerous lesion in the process of tamoxifen-induced malignant transformation of endometriosis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Antineoplastic Agents, Hormonal / adverse effects*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Carcinoma, Endometrioid / chemically induced
  • Carcinoma, Endometrioid / etiology*
  • Carcinoma, Endometrioid / pathology
  • Cell Transformation, Neoplastic / drug effects
  • Cell Transformation, Neoplastic / pathology
  • Endometriosis / complications
  • Endometriosis / pathology
  • Female
  • Humans
  • Neoplasms, Second Primary / chemically induced
  • Neoplasms, Second Primary / etiology*
  • Neoplasms, Second Primary / pathology
  • Ovarian Cysts / complications*
  • Ovarian Cysts / pathology
  • Ovarian Neoplasms / chemically induced
  • Ovarian Neoplasms / etiology*
  • Ovarian Neoplasms / pathology
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen